[
1. Solano-Gallego L, Miró G, Koutinas A, Cardoso L, Pennisi MG, Ferrer L, Bourdeau P, Oliva G, Baneth G, The LeishVet Group: LeishVet guidelines for the practical management of canine leishmaniosis. Parasit Vectors 2011, 4:86.10.1186/1756-3305-4-86312538121599936
]Search in Google Scholar
[
2. Gonçalves AAM, Leite JC, Resende LA, Mariano RMDS, Silveira P, Melo-Júnior OAO, Ribeiro HS, de Oliveira DS, Soares DF, Santos TAP, Marques AF, Galdino AS, Martins-Filho OA, Dutra WO, da Silveira-Lemos D, Giunchetti RC: An Overview of immunotherapeutic approaches against canine visceral leishmaniasis: What has been tested on dogs and a new perspective on improving treatment efficacy. Front Cell Infect Microbiol 2019, 9: 427.10.3389/fcimb.2019.00427693014631921703
]Search in Google Scholar
[
3. Esse R, Barroso M, de Almeida IT, Castro R: The Contribution of homocysteine metabolism disruption to endothelial dysfunction: State-of-the-art. Int J Mol Sci 2019, 20 (4): 867.10.3390/ijms20040867641252030781581
]Search in Google Scholar
[
4. Solano-Gallego L, Koutinas A, Miró G, Cardoso L, Pennisi MG, Ferrer L, Bourdeau P, Oliva G, Baneth G: Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis. Vet Parasitol 2009, 165 (1-2): 1-1810.1016/j.vetpar.2009.05.02219559536
]Search in Google Scholar
[
5. de Sousa Gonçalves R, de Pinho FA, Dinis-Oliveira RJ, Mendes MO, de Andrade TS, da Silva Solcà M, Larangeira DF, Silvestre R, Barrouin-Melo SM: Nutritional adjuvants with antioxidant properties in the treatment of canine leishmaniasis. Vet Parasitol 2021, 298: 109526.10.1016/j.vetpar.2021.10952634271314
]Search in Google Scholar
[
6. Patterson BE, Barr JW, Fosgate GT, Berghoff N, Steiner JM, Suchodolski JS, Black DM: Homocysteine in dogs with systemic inflammatory response syndrome. J Small Anim Pract. 2013, 54 (12): 620-624.10.1111/jsap.1214424283416
]Search in Google Scholar
[
7. Benvenuti E, Pierini A, Gori E, Bottero E, Pietra M, Lippi I, Meucci V, Marchetti V: Serum homocysteine concentration in dogs with immunosuppressant-responsive enteropathy. J Vet Sci 2020, 21 (4): e47.10.4142/jvs.2020.21.e47740293732735090
]Search in Google Scholar
[
8. Martínez-Subiela S, Bernal LJ, Cerón JJ. Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment. Am J Vet Res 2003, 64 (8): 1021-1026.10.2460/ajvr.2003.64.102112926596
]Search in Google Scholar
[
9. Pavićević Z, Laušević D, Pejović N: Seroprevalence of dogs to Leishmania infantum antigens in the territory of Crna Gora. Vet Glasnik 2014, 68 (5-6): 301-309.10.2298/VETGL1406301P
]Search in Google Scholar
[
10. Milanović Z, Ilić A, Francuski Andrić J, Radonjić V, Beletić A, Kovačević Filipović M: Acute-phase response in Babesia canis and Dirofilaria immitis co-infections in dogs. Ticks Tick Borne Dis 2017, 8 (6): 907-914.10.1016/j.ttbdis.2017.07.00928802807
]Search in Google Scholar
[
11. Jones GE, Mould DL: Adaptation of the guaiacol (peroxidase) test for haptoglobins to a microtitration plate system. Res Vet Sci 1984, 37: 87-92.10.1016/S0034-5288(18)31933-7
]Search in Google Scholar
[
12. Ceron JJ, Martinez-Subiela S: An automated spectrophotometric method for measuring canine ceruloplasmin in serum. Vet Res 2004, 35: 671-679.10.1051/vetres:2004046
]Search in Google Scholar
[
13. Dantoine TF, Debord J, Charmes JP, Merle L, Marquet P, Lachatre J, Leroux-Robert C: Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 1998, 9: 2082-2088.10.1681/ASN.V9112082
]Search in Google Scholar
[
14. Ellman E: Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82: 70-77.10.1016/0003-9861(59)90090-6
]Search in Google Scholar
[
15. Rossi G, Giordano A, Breda S, Lisi C, Roura X, Zatelli A, Paltrinieri S: Big-endothelin 1 (big ET-1) and homocysteine in the serum of dogs with chronic kidney disease. Vet J 2013, 198 (1): 109-115.10.1016/j.tvjl.2013.06.02223899407
]Search in Google Scholar
[
16. Lee CM, Jeong DM, Kang MH, Kim SG, Han JI, Park HM: Correlation between serum homocysteine concentration and severity of mitral valve disease in dogs. Am J Vet Res 017, 78 (4): 440-446.10.2460/ajvr.78.4.44028345991
]Search in Google Scholar
[
17. Grützner N, Suchodolski JS, Steiner JM: Relationship between cobalamin-dependent metabolites and both serum albumin and alpha1-proteinase inhibitor concentrations in hypocobalaminemic dogs of 7 different breeds. Vet Clin Pathol 2014, 43 (4): 561-566.10.1111/vcp.1220425331651
]Search in Google Scholar
[
18. Gołyński M, Lutnicki K, Krumrych W, Szczepanik M, Gołyńska M, Wilkołek P, Adamek Ł, Sitkowski Ł, Kurek Ł: Relationship between total homocysteine, folic acid, and thyroid hormones in hypothyroid dogs. J Vet Intern Med 2017, 31 (5): 1403-1405.10.1111/jvim.14804559888128804925
]Search in Google Scholar
[
19. Koutinas AF, Koutinas CK: Pathologic mechanisms underlying the clinical findings in canine leishmaniasis due to Leishmania infantum/chagasi. Vet Pathol 2014, 51 (2): 527-538.10.1177/030098581452124824510947
]Search in Google Scholar
[
20. Cantos-Barreda A, Escribano D, Cerón JJ, Bernal LJ, Furlanello T, Tecles F, Pardo-Marín L, Martínez-Subiela S: Relationship between serum anti-Leishmania antibody levels and acute phase proteins in dogs with canine leishmaniosis. Vet Parasitol 2018, 260: 63-68.10.1016/j.vetpar.2018.08.01030197018
]Search in Google Scholar
[
21. Hortin GL, Seam N, Hoehn GT: Bound homocysteine, cysteine, and cysteinylglycine distribution between albumin and globulins. Clin Chem 2006, 52 (12): 2258-2264.10.1373/clinchem.2006.07430217068168
]Search in Google Scholar
[
22. Daza González MA, Fragío Arnold C, Fermín Rodríguez M, Checa R, Montoya A, Portero Fuentes M, Rupérez Noguer C, Martínez Subiela S, Cerón JJ, Miró G: Effect of two treatments on changes in serum acute phase protein concentrations in dogs with clinical leishmaniosis. Vet J 2019, 245: 22-28.10.1016/j.tvjl.2018.12.02030819422
]Search in Google Scholar
[
23. Kather S, Grützner N, Kook PH, Dengler F, Heilmann RM: Review of cobalamin status and disorders of cobalamin metabolism in dogs. J Vet Intern Med 2020, 34 (1): 13-28.10.1111/jvim.15638697911131758868
]Search in Google Scholar
[
24. Dorlo TP, Balasegaram M, Beijnen JH, de Vries PJ: Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J Antimicrob Chemother 2012, 67 (11): 2576-2597.10.1093/jac/dks27522833634
]Search in Google Scholar
[
25. Noga AA, Stead LM, Zhao Y, Brosnan ME, Brosnan JT, Vance DE: Plasma homocysteine is regulated by phospholipid methylation. J Biol Chem 2003, 278 (8): 5952-5955.10.1074/jbc.M21219420012482759
]Search in Google Scholar
[
26. Ríos-Marco P, Marco C, Gálvez X, Jiménez-López JM, Carrasco MP: Alkylphospholipids: An update on molecular mechanisms and clinical relevance. Biochim Biophys Acta Biomembr 2017, 1859: 1657-1667.10.1016/j.bbamem.2017.02.01628238819
]Search in Google Scholar
[
27. Andersson A, Isaksson A, Hultberg B: Homocysteine export from erythrocytes and its implication for plasma sampling. Clin Chem 1992, 38 (7): 1311-1315.10.1093/clinchem/38.7.1311
]Search in Google Scholar
[
28. Perła-Kaján J, Jakubowski H: Paraoxonase 1 and homocysteine metabolism. Amino Acids 2012, 43 (4): 1405-1417.10.1007/s00726-012-1321-z22643843
]Search in Google Scholar
